Three affordable lenses, designed to help correct and control myopia in young patients, are now available from Opticare.
According to George Nasser, owner of Opticare, each of these premium lenses has a unique approach to managing the progression of myopia while providing optimal vision.
MyoEase, a lens designed by a collaborative American, Argentinian, and Chinese research team, features a multi-pinhole, micro-transparent lens defocus design. The pinholes are evenly arranged in a ring to form an optical defocus area, which is integrated into the phsyiological curvature of the retina to slow the growth rate of the eye axis. The MyoEase is available in 1.56, 1.6, 1.67 and 1.74 clear, Blue Guardian and Skye multicoating.
MyOnic, a freeform lens designed in Italy by ProCrea Tech, uses para-central hyperopic defocus to reduce axial length growth, correcting myopia at the fovea and simultaneously defocussing the peripheral hyperopia. Myonic is available in 25 different materials including 1.56, 1.6 and 1.67 with Blue Guardian and Skye multicoating.
The third lens in the collection is ClearPro Relax, a conventional freeform lens designed to help reduce the effects of digitally-induced eyestrain and other visual stress.
Mr Nasser said the lens manufacturers have indicated that in a six-month study, MyoEase is 62% effective for myopia control, Myonic 40-50% effective and ClearProRelax, like bifocals, can improve myopia control by around 25%.
“I’m looking forward to getting these lenses into the market and receiving independent reviews – particularly on MyoEase and Myonic. I’ve ensured they are affordable – I’ll do anything I can do to help independents, that’s where I’m coming from,” he said.
